Capital International Sarl’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-315,588
| Closed | -$2.79M | – | 232 |
|
|
2023
Q1 | $2.79M | Buy |
315,588
+44,066
| +16% | +$390K | 0.14% | 153 |
|
|
2022
Q4 | $2.48M | Buy |
271,522
+87,507
| +48% | +$798K | 0.17% | 139 |
|
|
2022
Q3 | $1.49M | Buy |
+184,015
| New | +$1.49M | 0.12% | 165 |
|
|
2022
Q1 | – | Sell |
-23,286
| Closed | -$187K | – | 275 |
|
|
2021
Q4 | $187K | Hold |
23,286
| – | – | 0.01% | 257 |
|
|
2021
Q3 | $227K | Sell |
23,286
-29,228
| -56% | -$285K | 0.02% | 236 |
|
|
2021
Q2 | $520K | Sell |
52,514
-13,564
| -21% | -$134K | 0.04% | 209 |
|
|
2021
Q1 | $763K | Sell |
66,078
-17,749
| -21% | -$205K | 0.07% | 182 |
|
|
2020
Q4 | $809K | Buy |
83,827
+22,757
| +37% | +$220K | 0.08% | 178 |
|
|
2020
Q3 | $550K | Buy |
61,070
+10,121
| +20% | +$91.2K | 0.07% | 180 |
|
|
2020
Q2 | $628K | Buy |
50,949
+38,749
| +318% | +$478K | 0.08% | 158 |
|
|
2020
Q1 | $110K | Buy |
+12,200
| New | +$110K | 0.02% | 196 |
|